If he will direct the Office for Life Sciences to review the arrangements for pharmaceutical and medical biotech businesses to access samples of human tissue.

The Human Tissue Authority is currently assessing the impact of human tissue legislation and regulation on tissue-based research. This is of course primarily a matter for the Department of Health.

I thank the Minister for that reply, but lack of access to human tissue samples is impeding research in the fight against cancer and other diseases. Most human tissue removed in surgeries is currently incinerated, but with patient consent it can be put to very good use. Will the Minister ask the Office for Life Sciences to look into creating a database to record what samples are available where across the country in order to help academics and biotech companies to achieve scientific breakthroughs?

The hon. Lady is right that bioscience is hugely important. For research on Alzheimer's, Parkinson's disease and schizophrenia, access to human tissue can mean real advances. The Office for Life Sciences is co-ordinating activity and I am pleased that the Department of Health is among the group of Departments represented. She will also be aware that in March this year the HTA announced a project to assess the impact of tissue legislation and regulation on tissue-based research.